This article was originally published in The Rose Sheet
Executive SummaryCarl Kooyoomjian appointed Exec VP, technical affairs and worldwide operations, effective immediately, Revlon announces June 26. Reporting to President and CEO Jack Stahl, Kooyoomjian will head global operations and research and development, firm says. Exec replaces Elias Hebeka, PhD, who is retiring at the end of the year. Kooyoomjian joins the company from Pacer International, a logistic company where he served as vice chairman. Prior to his career with Pacer, the exec was corporate VP and director for commercial products supply and manufacturing for the Coca-Cola company...
You may also be interested in...
Oncologic Drugs Advisory Committee will consider whether a statistically significant benefit on progression-free survival, but no survival advantage, is enough to secure a first-line lung cancer indication for ramucirumab.
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”
Perrigo has received US FDA approval for a generic version of Teva’s ProAir albuterol inhaler. The firm is immediately launching a “limited quantity” but is also ramping up production with partner Catalent to meet future demand.